This inventor holds 1 USPTO granted patent. Top assignee: Public University Corporation Nagoya City University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Isamu Ogawa: Innovator in Intestinal Organoid Research
Introduction
Isamu Ogawa is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of regenerative medicine, particularly in the development of intestinal organoids derived from pluripotent stem cells. His innovative work aims to advance our understanding of intestinal biology and potential therapeutic applications.
Latest Patents
Isamu Ogawa holds a patent for a "Method for producing intestinal organoid derived from pluripotent stem cells." The objective of this invention is to prepare a functional intestinal organoid from pluripotent stem cells. The process involves several steps: first, differentiating pluripotent stem cells into endoderm-like cells; second, differentiating these endoderm-like cells into intestinal stem cell-like cells; third, culturing the intestinal stem cell-like cells to form spheroids; and finally, differentiating the spheroids to form an intestinal organoid. This method includes the use of various inhibitors and growth factors to ensure successful differentiation and organoid formation.
Career Highlights
Isamu Ogawa is affiliated with the Public University Corporation Nagoya City University, where he conducts his research. His work has garnered attention for its potential impact on regenerative medicine and the treatment of intestinal disorders. With 1 patent to his name, Ogawa continues to push the boundaries of scientific research in his field.
Collaborations
Isamu Ogawa collaborates with esteemed colleagues such as Tamihide Matsunaga and Takahiro Iwao. Their combined expertise enhances the research efforts at Nagoya City University, fostering an environment of innovation and discovery.
Conclusion
Isamu Ogawa's contributions to the field of intestinal organoid research exemplify the importance of innovation in regenerative medicine. His patented methods pave the way for future advancements in understanding and treating intestinal diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile